| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |